Cancer Home > Ontek

Were you looking for more information about Ontak? Ontek is a common misspelling of Ontak.
Ontak® (denileukin diftitox) is a medication that is available by prescription only. It is approved for treating a type of cutaneous T-cell lymphoma that has a certain protein called interleukin-2 (IL-2) receptors. Ontak works by binding to these proteins and releasing diphtheria toxin, which kills the cancer cells. A healthcare provider will administer the drug using an intravenous (IV) infusion for five days in a row, once every three weeks.
(Click Ontak for more information about how it works, side effects to look out for during treatment, and when and how the medication is administered. You can also click any of the links in the box to the right for specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.